Cost-effectiveness analysis of selective first-line use of...

Cost-effectiveness analysis of selective first-line use of biologics for unresectable RAS wild-type left-sided metastatic colorectal cancer

Wong, W. W.L., Zargar, M., Berry, S. R., Ko, Y. J., Riesco-Martínez, M., Chan, K. K.W.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
26
Language:
english
Journal:
Current Oncology
DOI:
10.3747/co.26.4843
Date:
October, 2019
File:
PDF, 1.12 MB
english, 2019
Conversion to is in progress
Conversion to is failed